Alec Barclay

Insider Reports History

Location
Lexington, MA
Signature
/s/ John Sprague, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alec Barclay:

Form 4 holding Chief Operations Officer

T2 Biosystems, Inc.

Security class
Common Stock
Shares / value
181,945
Estimated value
$28,656
Report date
08 Apr 2022
Price
$0.1575
Ownership
Direct

Insider Reports Filed by Alec Barclay

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .